GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Procter & Gamble Health Ltd

Procter & Gamble Health Q1 FY27 Net Profit up to ₹9,615 Lakhs

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 06 Aug 2026, 02:03 PM IST  ·  BSE ID: e5553ca3-463d-48dc-a79f-e03d72769098
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported its latest quarterly financial results, including an increase in profit due to a property sale.
🤖 AI Summary
  • Procter & Gamble Health Ltd. approved Unaudited Financial Results for the quarter ended June 30, 2026.
  • Revenue from Operations for the quarter was ₹36,371 Lakhs, with Total Income reaching ₹36,759 Lakhs.
  • Net Profit for the period, after exceptional items, stood at ₹9,615 Lakhs.
  • An exceptional gain of ₹3,180 Lakhs resulted from the sale of office premises property.
  • Basic and Diluted Earnings Per Share (after exceptional items) for the quarter was ₹57.92 per share.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from Operations (Q1 FY27)
36371 Lakhs
7.30
Total Income (Q1 FY27)
36759 Lakhs
7.24
Net Profit for the period (Q1 FY27)
9615 Lakhs
44.97
Exceptional Item (Q1 FY27)
3180 Lakhs
Basic and Diluted EPS (after exceptional items) (Q1 FY27)
57.92
45.27
🏢 How This Affects the Company
📈
Business Impact
The company's primary business segment remains Pharmaceuticals, with no separate segment information provided per Ind AS 108.
💰
Financial Impact
Net profit was significantly boosted by an exceptional gain of ₹3,180 Lakhs from property sale, increasing overall profitability for the quarter.
⚙️
Operational Impact
The sale of office premises indicates a change in asset base, but the direct operational impact on current business activities is not specified.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the reported financial performance, including the Basic and Diluted EPS of ₹57.92 (after exceptional items) for the quarter.
🔍
Management Signal
Management reported an exceptional gain from property sale, indicating active asset management and potential capital reallocation.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q2 FY27 results — evaluate core revenue and profit growth without exceptional items.
Updates on utilization of funds from the office premises sale.
Details on any further asset optimization strategies by management.
LOW RISK No material adverse findings or significant new risks identified in the financial results.
💡 Investor Takeaway
Procter & Gamble Health Ltd.'s Net Profit for Q1 FY27 increased to ₹9,615 Lakhs, largely driven by an exceptional gain of ₹3,180 Lakhs from the sale of office premises. Total Income rose to ₹36,759 Lakhs from ₹34,277 Lakhs in the prior comparable quarter.
⚖️ Strengths & Concerns

✅ Positives

  • Net Profit for the period increased to ₹9,615 Lakhs in Q1 FY27, up from ₹8,990 Lakhs in the preceding quarter ended March 31, 2026.
  • Total Income for the quarter ended June 30, 2026, was ₹36,759 Lakhs, showing growth from ₹34,277 Lakhs in the corresponding quarter of FY26.

⚠️ Concerns

  • Profit before exceptional items and tax for the quarter ended June 30, 2026, was ₹9,731 Lakhs, a decrease from ₹13,321 Lakhs in the preceding quarter.
  • Total expenses for the quarter increased to ₹27,027 Lakhs, up from ₹25,396 Lakhs in the corresponding quarter of the previous year.
📅 Company Track Record
In a prior filing on August 6, 2026, Procter & Gamble Health announced Q1 FY27 sales up 7% to ₹356 crores and reported PAT up 45% to ₹96 crores. This current filing details the unaudited financial results, confirming these figures in Lakhs.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Procter & Gamble Health Ltd.'s Net Profit for the quarter ended June 30, 2026?
Procter & Gamble Health Ltd.'s Net Profit for the quarter ended June 30, 2026, was ₹9,615 Lakhs.
What was the Revenue from Operations for Procter & Gamble Health Ltd. in Q1 FY27?
The Revenue from Operations for Procter & Gamble Health Ltd. for the quarter ended June 30, 2026, was ₹36,371 Lakhs.
Did Procter & Gamble Health Ltd. report any exceptional items in Q1 FY27?
Yes, Procter & Gamble Health Ltd. reported an exceptional gain of ₹3,180 Lakhs from the sale of office premises property during the quarter ended June 30, 2026.
What was the Basic and Diluted EPS for Procter & Gamble Health Ltd. in Q1 FY27?
The Basic and Diluted Earnings Per Share (after exceptional items) for Procter & Gamble Health Ltd. for the quarter ended June 30, 2026, was ₹57.92 per share.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.